BlackRock Institutional Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.07M	Buy	339,172 +11,001	+3%	+$315K	﹤0.01%	2524
2016 Q3	$12M	Buy	328,171 +3,285	+1%	+$94.2K	﹤0.01%	2234
2016 Q2	$7.25M	Buy	324,886 +2,349	+0.7%	+$58.4K	﹤0.01%	2487
2016 Q1	$6.71M	Sell	322,537 -10,442	-3%	-$258K	﹤0.01%	2513
2015 Q4	$10.1M	Buy	332,979 +6,504	+2%	+$197K	﹤0.01%	2317
2015 Q3	$8.06M	Sell	326,475 -15,977	-5%	-$477K	﹤0.01%	2435
2015 Q2	$11M	Buy	342,452 +15,539	+5%	+$594K	﹤0.01%	2348
2015 Q1	$11.7M	Buy	326,913 +371	+0.1%	+$10.2K	﹤0.01%	2297
2014 Q4	$7.41M	Sell	326,542 -5,480	-2%	-$111K	﹤0.01%	2533
2014 Q3	$6.44M	Buy	332,022 +677	+0.2%	+$19.1K	﹤0.01%	2563
2014 Q2	$12M	Buy	331,345 +12,908	+4%	+$439K	﹤0.01%	2317
2014 Q1	$12.4M	Buy	318,437 +14,644	+5%	+$522K	﹤0.01%	2281
2013 Q4	$8.66M	Buy	303,793 +34,145	+13%	+$1M	﹤0.01%	2498
2013 Q3	$9.65M	Sell	269,648 -22,563	-8%	-$823K	﹤0.01%	2387
2013 Q2	$9.76M	Buy	+292,211	New	+$13.2M	﹤0.01%	2330